Mednet Logo
HomeOphthalmologyQuestion

What is your approach to immunosuppression in patients with recurrent peripheral ulcerative keratitis or marginal keratitis who have active disease despite steroid therapy and no current evidence of rheumatologic disease?

2
4 Answers
Mednet Member
Mednet Member
Rheumatology · University of Colorado School of Medicine

Drs. @Dr. First Last and @Dr. First Last provide some excellent insight in their responses. In this question, it's stated the patient has active disease despite steroids. I would agree with both Drs. @Dr. First Last and @Dr. First Last that non-infectious PUK typically requires high-dose steroid (1m...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Ophthalmology · Northwestern

This is a good question and something that can eventually be frustrating to treat if your initial few therapies aren’t enough. First, I want to distinguish between peripheral ulcerative keratitis and what you may be referring to as staph marginal? Staph marginal are small peripheral ulcerations usua...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

The terms peripheral ulcerative keratitis (PUK), marginal keratolysis, and corneal melt are all roughly equivalent. As Dr. @Dr. First Last wrote, it is important to exclude other conditions. Occasionally herpes simplex infection could mimic this. Mooren's ulcer and Terrien's marginal degeneration ar...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

I agree with both my colleagues that there can be a "prozone" effect with the ANCA such that false negative results occur and antibodies to PR-3 or MPO are detectable. The disagreement is with the word "screening". I screen with the ANCA and request antibodies to MPO and PR-3 in circumstances in whi...

Register or Sign In to see full answer